Results 181 to 190 of about 116,751 (358)

Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paltusotine is a novel, nonpeptide, selective somatostatin receptor 2 agonist in development for the treatment of acromegaly and carcinoid syndrome. This study investigated the mass balance, routes of excretion, absolute bioavailability and metabolite profile of orally administered paltusotine.
Rosa Luo   +6 more
wiley   +1 more source

Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase‐1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Dipeptidyl peptidase‐1 (DPP‐1) inhibitors have been studied for the treatment of neutrophil‐mediated inflammatory diseases including bronchiectasis, bronchial asthma and cystic fibrosis. This study evaluated the pharmacokinetics, pharmacodynamics, safety and tolerability of DPP‐1 inhibitor HSK31858 in healthy Chinese volunteers.
Yuhao Wang   +7 more
wiley   +1 more source

The Illusion of Performance: The Effect of Phantom Display Refresh Rates on User Expectations and Reaction Times [PDF]

open access: yesarXiv
User expectations impact the evaluation of new interactive systems. Increased expectations may enhance the perceived effectiveness of interfaces in user studies, similar to a placebo effect observed in medical studies. To showcase the placebo effect, we conducted a user study with 18 participants who performed a target selection reaction time test with
arxiv  

The effect of Barberry Juice supplement on Prostaglandin E2 level caused by intense aerobic activity in active young girls

open access: yesمجله دانشگاه علوم پزشکی بیرجند, 2017
Background and Aim: Intense exercise can cause damages caused by oxidative stress and inflammation and, as a result, reduce exercise performance. The present study aimed at determining the effect of barberry juice supplement on the inflammation caused by
Babak Hooshmand Moghadam   +2 more
doaj  

Weiße Kittel, Schwarze Magie : Placebo nutzen, Nocebo kennen [PDF]

open access: yes, 2013
Rezension zu: Magnus Heier, Andreas S. Ziegler: Weiße Kittel – Schwarze Magie. Placebos und Nocebos als Blendwerk der Medizin.
Hardy, Anne
core  

Do placebos alter sleep? [PDF]

open access: bronze, 1976
K Adám   +3 more
openalex   +1 more source

Pharmacology and safety of TAS5315, a Bruton tyrosine kinase inhibitor, in healthy volunteers: First‐in‐human, randomized, ascending‐dose studies

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim TAS5315 is a Bruton tyrosine kinase (Btk) inhibitor in development for autoimmune and allergic diseases, including rheumatoid arthritis (RA) and chronic spontaneous urticaria (CSU). Two clinical studies evaluated the pharmacology and safety of single and multiple oral doses of TAS5315.
Yuji Kumagai   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy